DISTRIBUTION OF B-10 AFTER INFUSION OF (NA2B12H11SH)-B-10 INTO A PATIENT WITH MALIGNANT ASTROCYTOMA - IMPLICATIONS FOR BORON NEUTRON-CAPTURE THERAPY

被引：16
|
作者：
FINKEL, GC
POLETTI, CE
FAIRCHILD, RG
SLATKIN, DN
SWEET, WH
机构：
[1] BROOKHAVEN NATL LAB,DEPT MED,BLDG 490,UPTON,NY 11973
[2] MASSACHUSETTS GEN HOSP,DEPT NEUROL SURG,BOSTON,MA 02114
来源：
NEUROSURGERY | 1989年 / 24卷 / 01期
关键词：
D O I：
10.1227/00006123-198901000-00002
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：6 / 11
页数：6
相关论文
共 50 条
  • [31] Na2B12H11SH (BSH) in combination with systemic hyaluronidase: A promising concept for boron neutron capture therapy for glioblastoma - Comment
    Sweet, WH
    NEUROSURGERY, 1996, 39 (02) : 325 - 326
  • [32] INVITRO INDUCTION OF CHROMOSOMAL-ABERRATIONS IN HUMAN-LYMPHOCYTES, WITH AND WITHOUT B-10, BY RADIATIONS CONCERNED IN BORON NEUTRON-CAPTURE THERAPY
    LLOYD, DC
    EDWARDS, AA
    PROSSER, JS
    FINNON, P
    MOQUET, JE
    BRITISH JOURNAL OF RADIOLOGY, 1988, 61 (732): : 1136 - 1141
  • [33] THE NUCLEAR-QUADRUPOLE COUPLING OF B-10 AND B-11 IN THE CARBORANES B10C2H12
    LOTZ, A
    VOITLANDER, J
    JOURNAL OF CHEMICAL PHYSICS, 1991, 95 (05): : 3208 - 3212
  • [34] The compound factor of Na2B12H11SH and the relative biological effectiveness of recoil protons for neurological damage in boron neutron capture therapy
    Gabel, D
    Philipp, KHI
    Huiskamp, R
    CANCER NEUTRON CAPTURE THERAPY, 1996, : 815 - 821
  • [35] Boron uptake of BSH (Na2B12H11SH) with time interval from BSH infusion in patients with malignant glioma
    Kageji, T
    Kitamura, K
    Hatanaka, H
    Nakagawa, Y
    ADVANCES IN NEUTRON CAPTURE THERAPY, VOLS I AND II: VOL I: MEDICINE AND PHYSICS, VOL II: CHEMISTRY AND BIOLOGY, 1997, 1132 : B197 - B201
  • [36] Pharmacokinetics of Na2B12H11SH (BSH) in patients with malignant brain tumours as prerequisite for a phase I clinical trial of boron neutron capture
    Gabel, D
    Preusse, D
    Haritz, D
    Grochulla, F
    Haselsberger, K
    Fankhauser, H
    Ceberg, C
    Peters, HD
    Klotz, U
    ACTA NEUROCHIRURGICA, 1997, 139 (07) : 606 - 612
  • [37] Pharmacokinetics of Na2B12H11SH (BSH) in patients with malignant brain tumours as prerequisite for a phase I clinical trial of boron neutron capture
    D. Gabel
    D. Preusse
    D. Haritz
    F. Grochulla
    K. Haselsberger
    H. Fankhauser
    C. Ceberg
    H. -D. Peters
    U. Klotz
    Acta Neurochirurgica, 1997, 139 : 606 - 612
  • [38] MEASUREMENT OF AUGMENTATION OF CF-252 IMPLANT BY B-10 AND GD-157 NEUTRON-CAPTURE
    WIERZBICKI, JG
    MARUYAMA, Y
    PORTER, AT
    MEDICAL PHYSICS, 1994, 21 (06) : 787 - 790
  • [39] Spectromicroscopy of boron in human glioblastomas following administration of Na2B12H11SH
    Gilbert, B
    Perfetti, L
    Fauchoux, O
    Redondo, J
    Baudat, PA
    Andres, R
    Neumann, M
    Steen, S
    Gabel, D
    Mercanti, D
    Ciotti, MT
    Perfetti, P
    Margaritondo, G
    De Stasio, G
    PHYSICAL REVIEW E, 2000, 62 (01): : 1110 - 1118
  • [40] Pharmacokinetics of Na2B12H11SH (BSH) in patients with malignant brain tumours as prerequisite for a phase I clinical trial of boron neutron capture - Comments
    Reulen, H
    ACTA NEUROCHIRURGICA, 1997, 139 (07) : 611 - 612
12345